Charities must be clear about pharma funding
October 1, 2014Medical Communications, Sales and Marketing ABPI, NICE, Sativex, charity, funding, mind, pharma
There is growing need for transparency around patient groups and health charities as they are widely perceived to be independent …
J&J bets $1.75 billion on virology
October 1, 2014Research and Development, Sales and Marketing AL-8176, Alios BioPharma, J&J, JJ, Janssen, sovaldi, viral
Johnson & Johnson has signed a deal to acquire Alios BioPharma, a privately-held company focussed on developing therapies for viral …
Chemia appoints network manager
October 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Duncanson-Hunter, Pan, Red Door, chemia
Creston Health-owned network of agencies offering Chemia has hired a manager to run its operations. Ellie Duncanson-Hunter has been appointed …
SHL to introduce product Case Studies at the 2014 PDA Conference
October 1, 2014Sales and Marketing auto injectors, case studies, pen injectors, shl group
Taking an advanced injection device from concept to reality requires careful planning, key design and manufacturing competencies and a thorough …
Boehringer spends €100 million on inhaler
September 30, 2014Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat
Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
UK to ‘guarantee’ seven-day access to GPs
September 30, 2014Medical Communications, Research and Development, Sales and Marketing BMA, Cameron, GPs, NHS, UK, doctors
Under a UK Conservative government everyone would have access to GP care seven days a week as well as a …
Gilead to shift plant and expand US manufacturing
September 30, 2014Manufacturing and Production AmBisome, Cayston, Gilead, San Dimas, Viread, california, manufacturing
Gilead Sciences will move its US manufacturing plant about 15 minutes down the road to a 23-acre site in the …
New director for NHS England
September 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, richard jeavons
Richard Jeavons will be joining NHS England as its new director of specialised commissioning. Jeavons will report to Dame Barbara …
Lucideon expands pharma testing facilities
September 29, 2014Manufacturing and Production, Sales and Marketing bioburden, ceram, freeman, labs, lucideon, manufacturing, stoke
Materials development firm Lucideon has opened new pharmaceutical quality control testing laboratories at its UK headquarters in Stoke-on-Trent. The £1.5 …
BMS therapeutic cancer vaccine given swift FDA appraisal
September 29, 2014Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo
Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …
Boehringer’s lung cancer drug gets EMA nod
September 29, 2014Sales and Marketing Boehringer, IPF, docetaxel, ingelheim, lung cancer, nintedanib
The EMA has issued a positive opinion for the approval of Boehringer Ingelheim’s nintedanib in combination with docetaxel for the …
NHS stem cell research link up
September 29, 2014Research and Development, Sales and Marketing NHS, precious cells group, precious cells miracle, stem cell
Precious Cells Miracle, the charitable arm of stem cell firm Precious Cells Group, has partnered with the Croydon Health Services …
Sovaldi combo sees CHMP green light
September 29, 2014Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi
The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …
Roche’s Perjeta sees ‘impressive’ survival rates
September 29, 2014Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid
Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …
Daiichi Sankyo pays $410m for Ambit Biosciences
September 29, 2014Sales and Marketing AML, Daiichi Sankyo, ambit biosciences, quizartinib
Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. …
Adaptimmune board changes amid funding boost
September 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Ali Behbahani, Elliott Sigal, Peter Thompson, david mott
Oxford-based biotech firm Adaptimmune has secured some significant financial support whilst also making changes to its board. David Mott (pictured), …
Is clinical research management evidence-based?
September 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Six Sigma, clinical trials, evidence, neuro-linguistic
Those who follow my columns will know that I am in the habit of starting with reminiscences. It’s something that …
Novartis: digital pharma company of the year
September 26, 2014Medical Communications, Sales and Marketing London, McCann Manchester and Red Door Communications, Novartis, pm society
Novartis pipped Bayer and its big pharma rivals Boehringer, Genentech, GSK and Sanofi to the post in receiving the first …
Virgo Health appoints US office head
September 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, nancy caravetta
UK-based healthcare comms agency Virgo Health has launched a PR office in New York and appointed Nancy Caravetta to head …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
